Advanced search
Publication Cover
Gynecological Endocrinology Volume 36, 2020 - Issue 5
Submit an article Journal homepage
112
Views
6
CrossRef citations to date
0
Altmetric
MENOPAUSE

Ospemifene plus fractional CO2 laser: a powerful strategy to treat postmenopausal vulvar pain

F. MurinaLower Genital Tract Disease Unit, V. Buzzi Hospital, University of Milan, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-9966-6448View further author information
ORCID Icon,
R. FeliceLower Genital Tract Disease Unit, V. Buzzi Hospital, University of Milan, Milan, ItalyView further author information
,
S. Di FrancescoLower Genital Tract Disease Unit, V. Buzzi Hospital, University of Milan, Milan, ItalyView further author information
,
L. NelvastellioLower Genital Tract Disease Unit, V. Buzzi Hospital, University of Milan, Milan, ItalyView further author information
&
I. CetinLower Genital Tract Disease Unit, V. Buzzi Hospital, University of Milan, Milan, ItalyView further author information
Pages 431-435 | Received 04 Jun 2019, Accepted 11 Oct 2019, Published online: 22 Oct 2019

References

  • Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey. Climacteric. 2012;15:36–44.
  • Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health. 2013;5:437–447.
  • Portman DJ, Gass MLS. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063–1068.
  • Castelo-Branco C, Biglia N, Nappi RE, et al. Characteristics of post-menopausal women with genitourinary syndrome of menopause: Implications for vulvovaginal atrophy diagnosis and treatment selection. Maturitas. 2015;81(4):462–469.
  • Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc. 2017;92(12):1842–1849.
  • The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2018;25:1362–1387.
  • ACOG. Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123:202–216.
  • Bachman G, Santen R. Treatment of vaginal atrophy. Waltham (MA): Up To Date; 2014.
  • Portman D, Palacios S, Nappi RE, et al. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial. Maturitas. 2014;78(2):91–98.
  • Simon J, Portman D, Mabey RG, et al. Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women. Maturitas. 2014;77(3):274–281.
  • Athanasiou S, Pitsouni E, Falagas ME, et al. CO2-laser for the genitourinary syndrome of menopause. How many laser sessions? Maturitas. 2017;104:24–28.
  • Salvatore S, Athanasiou S, Candiani M. The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy. Curr Opin Obstet Gynecol. 2015;27(6):504–508.
  • Murina F, Karram M, Salvatore S, et al. Fractional CO2 laser treatment of the vestibule for patients with vestibulodynia and genitourinary syndrome of menopause: a pilot study. J Sex Med. 2016;13(12):1915–1917.
  • Lev-Sagie A. Vulvar and vaginal atrophy: physiology, clinical presentation, and treatment considerations. Clin Obstet Gynecol. 2015;58(3):476–491.
  • Graziottin A, Murina F. Vulvar Pain: From Childhood to Old Age [Internet]. Springer International Publishing; 2017. [cited 2019 May 22]. Available from: https://www.springer.com/gp/book/9783319426754.
  • Taras TL, Wurz GT, DeGregorio MW. In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer. J Steroid Biochem Mol Biol. 2001;77(4–5):271–279.
  • Brincat MP, Baron YM, Galea R. Estrogens and the skin. Climacteric. 2005;8(2):110–123.
  • Goldstein SW, Winter AG, Goldstein I. Improvements to the vulva, vestibule, urethral meatus, and vagina in women treated with ospemifene for moderate to severe dyspareunia: a prospective vulvoscopic pilot study. Sex Med. 2018;6(2):154–161.
  • Murina F, Di Francesco S, Oneda S. Vulvar vestibular effects of ospemifene: a pilot study. Gynecol Endocrinol. 2018;34(7):631–635.
  • Fitzpatrick RE, Rostan EF, Marchell N. Collagen tightening induced by carbon dioxide laser versus erbium: YAG laser. Laser Surg Med. 2000;27(5):395–403.
  • Nappi RE, Panay N, Bruyniks N, et al. The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy. Climacteric. 2015;18(2):233–240.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.